Aditxt, Inc. Preferred Stock Dividends and Other Adjustments
Aditxt, Inc. (ADTX) reported Preferred Stock Dividends and Other Adjustments of $319.87 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsAndOtherAdjustments · last filed 2024-04-16
- Aditxt, Inc. preferred stock dividends and other adjustments for the quarter ending 2023-12-31 was $152.70K.
- Aditxt, Inc. preferred stock dividends and other adjustments for the quarter ending 2023-09-30 was $167.17K.
- Aditxt, Inc. preferred stock dividends and other adjustments for fiscal 2023 was $319.87K, a 749.21% increase from fiscal 2022.
- Aditxt, Inc. preferred stock dividends and other adjustments for fiscal 2022 was $37.67K.
| Period end | Preferred Stock Dividends and Other Adjustments 3 month | Preferred Stock Dividends and Other Adjustments 6 month | Preferred Stock Dividends and Other Adjustments 9 month | Preferred Stock Dividends and Other Adjustments 12 month |
|---|---|---|---|---|
| 2023-12-31 | $152.70K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $319.87K derived: sum of 2 quarters · filed 2024-04-16 | $319.87K 10-K · filed 2024-04-16 | |
| 2023-09-30 | $167.17K 10-Q · filed 2023-11-14 | $167.17K 10-Q · filed 2023-11-14 | ||
| 2022-12-31 | $37.67K 10-K · filed 2024-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |